Recent studies have shown that in HNSCC, the expression levels of the ACSL1 and TFRC genes are closely related to the occurrence of tumour cell ferroptosis and the prognosis of patients and are potential targets for the occurrence, development and treatment of HNSCC [79]. This evidence concerns the gene TFRC and head and neck squamous cell carcinoma.